NVIDIA
NVDA
Tesla
TSLA
Disney
DIS
Apple
AAPL
Netflix
NFLX
US Stock MarketDetailed Quotes
IART Integra Lifesciences
- 23.210
- +0.150+0.65%
Close Feb 28 16:00 ET
- 23.210
- 0.0000.00%
Post 16:19 ET
1.79BMarket Cap-257.89P/E (TTM)
23.250High22.430Low698.61KVolume23.060Open23.060Pre Close16.09MTurnover1.06%Turnover RatioLossP/E (Static)77.22MShares37.17052wk High1.16P/B1.54BFloat Cap16.80552wk Low--Dividend TTM66.16MShs Float77.400Historical High--Div YieldTTM3.56%Amplitude1.500Historical Low23.026Avg Price1Lot Size
Integra Lifesciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -7.55%129.38M | -13.63%50.74M | -16.01%22.49M | 42.87%40.4M | -39.76%15.76M | -47.08%139.96M | -31.15%58.75M | -60.81%26.77M | -57.46%28.28M | -41.02%26.16M |
| Net income from continuing operations | -110.25%-6.94M | -2.01%19.44M | -154.86%-10.7M | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M |
| Operating gains losses | 92.54%1.5M | -79.64%159K | -28.00%72K | 1,646.91%1.25M | 152.17%12K | 110.42%777K | 110.11%781K | 121.65%100K | -505.00%-81K | -103.23%-23K |
| Depreciation and amortization | 14.07%140.89M | 21.31%37.59M | 17.68%35.96M | 19.31%36.78M | -1.85%30.57M | 4.41%123.51M | 5.05%30.99M | 3.70%30.56M | 4.10%30.83M | 4.77%31.14M |
| Deferred tax | -74.43%-20.73M | 52.94%-6.99M | -831.04%-9.04M | -712.33%-1.84M | -246.24%-2.86M | -159.21%-11.89M | -146.48%-14.85M | 120.27%1.24M | -105.68%-227K | -44.89%1.95M |
| Other non cash items | -57.21%9.09M | -12.57%5.34M | -140.50%-1.61M | 1.76%3.36M | -74.48%2M | 299.58%21.24M | 831.71%6.11M | 138.73%3.98M | 268.56%3.3M | 733.23%7.85M |
| Change In working capital | 61.99%-31.01M | -218.77%-11.99M | 109.96%3.39M | 106.26%938K | 45.20%-23.35M | -106.94%-81.57M | -1.59%10.09M | -969.18%-34.06M | 10.34%-14.99M | -43.14%-42.61M |
| -Change in receivables | 61.07%7.4M | -6,784.68%-31.46M | 12,734.82%28.75M | -28.78%-6.72M | 67.58%16.83M | 113.55%4.59M | 95.45%-457K | 101.57%224K | 19.97%-5.22M | 422.24%10.04M |
| -Change in inventory | 52.91%-28.15M | 96.53%-570K | 34.78%-10.3M | 181.75%1.74M | 25.18%-19.02M | -105.24%-59.77M | -250.84%-16.42M | -130.01%-15.8M | 64.56%-2.13M | -119.90%-25.42M |
| -Change in prepaid assets | -408.71%-8.19M | 7.65%26.21M | -57.56%-17.63M | -68.87%-14.1M | -23.66%-2.68M | -69.21%2.65M | 248.73%24.35M | -294.61%-11.19M | -1,001.51%-8.35M | 57.11%-2.16M |
| -Change in payables and accrued expense | 86.78%-2.67M | -380.33%-5.36M | 209.36%6.83M | 238.07%15.07M | -285.43%-19.21M | -216.64%-20.23M | -89.46%1.91M | -145.39%-6.24M | -127.30%-10.92M | 48.90%-4.98M |
| -Change in other current assets | 66.70%-2.84M | -559.00%-1.1M | -1,809.49%-11.27M | 522.16%9.18M | 105.64%339K | -291.15%-8.54M | 102.03%239K | -120.80%-590K | -148.82%-2.18M | -363.21%-6.01M |
| -Change in other current liabilities | 77.32%-93K | -395.86%-1.43M | 6,590.00%7.36M | -158.60%-7.91M | 113.02%1.89M | 90.76%-410K | -95.10%483K | 101.78%110K | 343.59%13.5M | -463.00%-14.5M |
| -Change in other working capital | 2,665.63%3.54M | 13,315.38%1.72M | 40.48%-347K | 1,147.28%3.67M | -448.37%-1.5M | -97.01%128K | -100.74%-13K | -133.31%-583K | --294K | --430K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -7.55%129.38M | -13.63%50.74M | -16.01%22.49M | 42.87%40.4M | -39.76%15.76M | -47.08%139.96M | -31.15%58.75M | -60.81%26.77M | -57.46%28.28M | -41.02%26.16M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -314.97%-390.81M | 92.58%-4.25M | -35.07%-10.4M | -1,972.28%-322.2M | -293.79%-53.97M | -60.77%-94.18M | -4.39%-57.23M | -151.99%-7.7M | -245.66%-15.55M | 2.58%-13.7M |
| Net PPE purchase and sale | -56.16%-104.42M | -20.64%-29.6M | -126.69%-29.65M | -91.07%-29.71M | -12.85%-15.47M | -114.32%-66.87M | -641.01%-24.54M | -42.85%-13.08M | -65.28%-15.55M | -46.96%-13.7M |
| Net intangibles purchase and sale | ---9.95M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---277.81M | --4.18M | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | 105.03%1.37M | 195.19%31.12M | 257.74%19.25M | ---10.5M | ---38.5M | -656.39%-27.31M | ---32.69M | --5.38M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -314.97%-390.81M | 92.58%-4.25M | -35.07%-10.4M | -1,972.28%-322.2M | -293.79%-53.97M | -60.77%-94.18M | -4.39%-57.23M | -151.99%-7.7M | -245.66%-15.55M | 2.58%-13.7M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 203.45%237.86M | -3.77%-7.15M | 59.90%-19.92M | -776.72%-93.75M | 320.48%358.68M | 8.74%-229.93M | 92.95%-6.89M | -549.82%-49.66M | 18.67%-10.69M | -21.89%-162.68M |
| Net issuance payments of debt | 449.30%299.37M | 30.11%-4.54M | -126.36%-19.74M | -171.32%-31.74M | 16,254.55%355.4M | 150.56%54.5M | 93.58%-6.5M | 1,252.31%74.9M | -2,440.00%-11.7M | -340.00%-2.2M |
| Net common stock issuance | 80.92%-52.47M | ---2.47M | --0 | ---50M | --0 | -120.00%-275M | --0 | ---125M | --0 | -20.00%-150M |
| Proceeds from stock option exercised by employees | 48.20%6.4M | --0 | --0 | --0 | 175.06%6.4M | -21.01%4.32M | -94.19%225K | --655K | 214.73%1.11M | 87.73%2.33M |
| Net other financing activities | -12.31%-15.43M | 77.89%-136K | 20.09%-171K | -11,442.31%-12M | 75.63%-3.12M | 44.18%-13.74M | -126.10%-615K | 81.26%-214K | 99.26%-104K | -39.17%-12.81M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 203.45%237.86M | -3.77%-7.15M | 59.90%-19.92M | -776.72%-93.75M | 320.48%358.68M | 8.74%-229.93M | 92.95%-6.89M | -549.82%-49.66M | 18.67%-10.69M | -21.89%-162.68M |
| Net cash flow | ||||||||||
| Beginning cash position | -39.47%276.4M | -21.40%215.16M | -30.39%215.24M | 92.57%591.91M | -39.47%276.4M | -11.06%456.66M | -46.53%273.73M | -30.85%309.19M | -24.50%307.37M | -11.06%456.66M |
| Current changes in cash | 87.20%-23.56M | 832.74%39.34M | 74.41%-7.83M | -18,527.13%-375.55M | 313.32%320.47M | -299.77%-184.15M | 92.01%-5.37M | -140.52%-30.59M | -95.83%2.04M | -45.59%-150.23M |
| Effect of exchange rate changes | -266.21%-6.46M | -201.04%-8.12M | 258.95%7.75M | -428.17%-1.13M | -629.67%-4.96M | 136.27%3.89M | -32.50%8.04M | 54.41%-4.87M | 97.57%-213K | 129.58%937K |
| End cash Position | -10.86%246.38M | -10.86%246.38M | -21.40%215.16M | -30.39%215.24M | 92.57%591.91M | -39.47%276.4M | -39.47%276.4M | -46.53%273.73M | -30.85%309.19M | -24.50%307.37M |
| Free cash flow | -79.46%15.01M | -67.30%11.19M | -152.30%-7.16M | -16.00%10.69M | -97.66%291K | -66.38%73.09M | -51.73%34.22M | -76.86%13.69M | -77.69%12.73M | -58.87%12.45M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
